CDK2 and breast carcinoma: Different indole and indole isosteres-based compounds were shown to potently inhibit cyclin-dependent kinase 2 (CDK2) activity as part of a G1 cell cycle arrest of human breast cancer cells [23,24,25,26,27,28,29].